New hope for tough blood cancers: first patients test experimental drug
NCT ID NCT05728658
Summary
This is the first study in people to test a new drug called ICP-248, given alone or with another cancer drug, for adults with certain relapsed or hard-to-treat B-cell blood cancers. The main goals are to find a safe dose, see how the body processes the drug, and get an early look at whether it helps shrink tumors. It will enroll about 191 patients who have not responded well to prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
Contact
-
Hematology Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, Tianjin Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450008, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410000, China
Contact
-
Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, 210029, China
Contact
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, 330029, China
Contact
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100191, China
Contact
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact
-
Shandong cancer hospital
RECRUITINGJinan, Shandong, 250117, China
Contact
-
Shenyang Hospital Of China Medical University
RECRUITINGShenyang, Liaoning, 110022, China
Contact
-
Sun Yat-Sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510062, China
Contact
-
The Central Hospital of Wuhan
RECRUITINGWuhan, Hubei, 430014, China
Contact
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230022, China
Contact
-
The First Affiliated Hospital of Bengbu Medical College
RECRUITINGBengbu, Anhui, 233099, China
Contact
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 400016, China
Contact
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330000, China
Contact
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361003, China
Contact
-
The First Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, 450008, China
Contact
-
The Second Hospital of Dalian Medical University
RECRUITINGDalian, Liaoning, 116027, China
Contact
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
Contact
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610000, China
Contact
Conditions
Explore the condition pages connected to this study.